Tobramycin Supplier-Buyer Network — Trade Flow Analysis

Name: Tobramycin Supplier-Buyer Trade Network Dataset — 283+ Indian Exporters, 15+ Importers, 134+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Tobramycin supplier network, Tobramycin buyers, pharmaceutical export India, Tobramycin trade data

TransData Nexus

Tobramycin

India Pharmaceutical Trade Intelligence

$39.2M283 Suppliers134 CountriesHS 30049099

ExportsIndia → UNITED STATES62.3%India → RUSSIA15.3%

ImportsUNITED STATES → India$498.0K CHINA → India$88.3K

#1 Supplier: MANKIND PHARMA #1 Buyer: LIFESTAR PHARMA

Who Supplies Tobramycin? Top Manufacturers & Buyers 2026 — MANKIND PHARMA LIMITED Leads | TransData Nexus | TransData Nexus

1MANKIND PHARMA LIMITED

MANKIND PHARMA LIMITED is the first-largest Tobramycin exporter from India, with a market share of 12.4% and a total export value of $4.9M across 78 shipments. Their average shipment value of $62.6K is above the market average of $14.7K, suggesting premium or bulk contract pricing.

MANKIND PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• LIFESTAR PHARMA LLC — $1.8M across 28 shipments (36.2% of this supplier's total exports)

• LIFESTAR PHARMA LLC — $1.2M across 20 shipments (25.2% of this supplier's total exports)

• LIFESTAR PHARMA LLCC/O RXCROSSROADS — $829.6K across 13 shipments (17.0% of this supplier's total exports)

• NORTHSTAR RX LLC — $556.2K across 9 shipments (11.4% of this supplier's total exports)

• LIFESTAR PHARMA LLCC/O RXCROSSROADS — $496.8K across 8 shipments (10.2% of this supplier's total exports)

Key Insight: MANKIND PHARMA LIMITED's per-shipment value of $62.6K is 327% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.

2SENTISS PHARMA PRIVATE LIMITED

SENTISS PHARMA PRIVATE LIMITED is the second-largest Tobramycin exporter from India, with a market share of 10.0% and a total export value of $3.9M across 60 shipments. Their average shipment value of $65.5K is above the market average of $14.7K, suggesting premium or bulk contract pricing.

SENTISS PHARMA PRIVATE LIMITED serves 4 named buyers in our database. LLC SENTISS RUS is the dominant customer, accounting for 87.1% of this supplier's tracked business. Top customers include:

• LLC SENTISS RUS — $3.4M across 52 shipments (87.1% of this supplier's total exports)

• LLC SENTISS RUS — $303.0K across 5 shipments (7.7% of this supplier's total exports)

• LLC SENTISS RUS — $131.3K across 2 shipments (3.3% of this supplier's total exports)

• LLC SENTISS RUS — $72.6K across 1 shipments (1.8% of this supplier's total exports)

Key Insight: SENTISS PHARMA PRIVATE LIMITED's per-shipment value of $65.5K is 347% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Tobramycin exporter from India, with a market share of 10.0% and a total export value of $3.9M across 77 shipments. Their average shipment value of $50.7K is above the market average of $14.7K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SUN PHARMACEUTICAL INDUSTRIES INC — $1.3M across 25 shipments (32.3% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $1.2M across 23 shipments (30.3% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES INC — $813.8K across 16 shipments (20.8% of this supplier's total exports)

• SUN PHARMA ANZ PTY LTD — $441.6K across 9 shipments (11.3% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES INC — $206.2K across 4 shipments (5.3% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $50.7K is 246% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.

4GLAND PHARMA LTD

GLAND PHARMA LTD is the fourth-largest Tobramycin exporter from India, with a market share of 8.5% and a total export value of $3.3M across 35 shipments. Their average shipment value of $94.9K is above the market average of $14.7K, suggesting premium or bulk contract pricing.

GLAND PHARMA LTD serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 79.0% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES — $2.6M across 28 shipments (79.0% of this supplier's total exports)

• STERIMAX INC — $373.2K across 4 shipments (11.2% of this supplier's total exports)

• NORTHSTAR DISTIBUTIO — $122.0K across 1 shipments (3.7% of this supplier's total exports)

• INTEGRATED COMMERCIA — $115.1K across 1 shipments (3.5% of this supplier's total exports)

• RAINBOW GOLD, INC — $86.2K across 1 shipments (2.6% of this supplier's total exports)

Key Insight: GLAND PHARMA LTD's per-shipment value of $94.9K is 547% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.

5MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the fifth-largest Tobramycin exporter from India, with a market share of 5.6% and a total export value of $2.2M across 45 shipments. Their average shipment value of $48.4K is above the market average of $14.7K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ALPHAPHARM PTY LTD — $620.3K across 13 shipments (28.5% of this supplier's total exports)

• MYLAN INSTITUTIONAL INC — $607.1K across 13 shipments (27.9% of this supplier's total exports)

• MYLAN INSTITUTIONAL INC — $523.1K across 11 shipments (24.0% of this supplier's total exports)

• MYLAN AUSTRALIA — $265.9K across 5 shipments (12.2% of this supplier's total exports)

• MYLAN INSTITUTIONAL INC — $161.8K across 3 shipments (7.4% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $48.4K is 230% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.

6GLAND PHARMA LIMITED

GLAND PHARMA LIMITED is the fifth-largest Tobramycin exporter from India, with a market share of 2.4% and a total export value of $944.5K across 17 shipments. Their average shipment value of $55.6K is above the market average of $14.7K, suggesting premium or bulk contract pricing.

GLAND PHARMA LIMITED serves 3 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES is the dominant customer, accounting for 80.8% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES — $763.0K across 14 shipments (80.8% of this supplier's total exports)

• INTEGRATED COMMERCIA — $111.5K across 2 shipments (11.8% of this supplier's total exports)

• STERIMAX INC — $70.0K across 1 shipments (7.4% of this supplier's total exports)

Key Insight: GLAND PHARMA LIMITED's per-shipment value of $55.6K is 279% above the market average of $14.7K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Tobramycin imports from India, with a total trade value of $24.5M across 239 shipments — representing a 62.3% share of all Tobramycin exports. The average shipment value of $102.4K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations. This market is served by 13 tracked buyers.

Named Tobramycin importers in United States: LIFESTAR PHARMA LLC is the largest buyer, accounting for 20.6% ($5.0M) of this market's total imports.

• LIFESTAR PHARMA LLC — $5.0M (20.6% of United States's total)

• EVERSANA LIFE SCIENCE SERVICES — $4.3M (17.5% of United States's total)

• RX CROSSROADS 3PL LLC — $2.0M (8.2% of United States's total)

Key Insight: United States's per-shipment average of $102.4K (598% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Tobramycin imports from India.

Primary Market

Secondary Market

2Russia

Russia ranks as the second-largest destination for Tobramycin imports from India, with a total trade value of $6.0M across 48 shipments — representing a 15.3% share of all Tobramycin exports. The average shipment value of $125.1K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Tobramycin importers in Russia: LLC SENTISS RUS is the largest buyer, accounting for 67.6% ($4.1M) of this market's total imports.

• LLC SENTISS RUS — $4.1M (67.6% of Russia's total)

• OOO"JODAS EXPOIM" — $1.1M (17.5% of Russia's total)

Key Insight: Russia's per-shipment average of $125.1K (753% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Tobramycin imports from India.

Primary Market

Secondary Market

3Belgium

Belgium ranks as the third-largest destination for Tobramycin imports from India, with a total trade value of $3.5M across 62 shipments — representing a 8.8% share of all Tobramycin exports. The average shipment value of $56.0K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Tobramycin importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 73.0% ($2.5M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $2.5M (73.0% of Belgium's total)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $934.7K (26.9% of Belgium's total)

Key Insight: Belgium's per-shipment average of $56.0K (282% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Tobramycin imports from India.

Primary Market

Secondary Market

4Australia

Australia ranks as the fourth-largest destination for Tobramycin imports from India, with a total trade value of $1.6M across 18 shipments — representing a 4.0% share of all Tobramycin exports. The average shipment value of $87.5K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Tobramycin importers in Australia: ALPHAPHARM PTY LTD is the largest buyer, accounting for 39.4% ($620.3K) of this market's total imports.

• ALPHAPHARM PTY LTD — $620.3K (39.4% of Australia's total)

• SUN PHARMA ANZ PTY LTD — $606.4K (38.5% of Australia's total)

Key Insight: Australia's per-shipment average of $87.5K (497% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Tobramycin imports from India.

Primary Market

Secondary Market

5Vietnam

Vietnam ranks as the fifth-largest destination for Tobramycin imports from India, with a total trade value of $668.4K across 0 shipments — representing a 1.7% share of all Tobramycin exports. The average shipment value of $668.4K is above the global average of $14.7K, indicating high-value procurement contracts or branded formulations.

Key Insight: Vietnam's per-shipment average of $668.4K (4458% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Vietnam is a key market for Tobramycin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Tobramycin.
2.Flow Mapping: 283 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,676 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 134 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,676 Verified Shipments

283 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Tobramycin

Tobramycin

Who Supplies Tobramycin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Tobramycin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Tobramycin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MANKIND PHARMA LIMITED

2SENTISS PHARMA PRIVATE LIMITED

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

4GLAND PHARMA LTD

5MYLAN LABORATORIES LIMITED

6GLAND PHARMA LIMITED

From Indian Factories to Global Pharmacies — How Tobramycin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Tobramycin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Russia

3Belgium

4Australia

5Vietnam

People Also Ask — Tobramycin Supplier & Trade Network

Tobramycin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology